These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10436346)

  • 1. Biochemical and molecular characterization of neurofibrillary degeneration in frontotemporal dementias.
    Delacourte A
    Dement Geriatr Cogn Disord; 1999; 10 Suppl 1():75-9. PubMed ID: 10436346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases.
    Sergeant N; David JP; Lefranc D; Vermersch P; Wattez A; Delacourte A
    FEBS Lett; 1997 Aug; 412(3):578-82. PubMed ID: 9276470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms.
    Sergeant N; Wattez A; Delacourte A
    J Neurochem; 1999 Mar; 72(3):1243-9. PubMed ID: 10037497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes.
    Mailliot C; Sergeant N; Bussière T; Caillet-Boudin ML; Delacourte A; Buée L
    FEBS Lett; 1998 Aug; 433(3):201-4. PubMed ID: 9744794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new neuropathology of degenerative frontotemporal dementias.
    Jackson M; Lowe J
    Acta Neuropathol; 1996; 91(2):127-34. PubMed ID: 8787144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease.
    Buée Scherrer V; Hof PR; Buée L; Leveugle B; Vermersch P; Perl DP; Olanow CW; Delacourte A
    Acta Neuropathol; 1996; 91(4):351-9. PubMed ID: 8928611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration.
    Bussière T; Hof PR; Mailliot C; Brown CD; Caillet-Boudin ML; Perl DP; Buée L; Delacourte A
    Acta Neuropathol; 1999 Mar; 97(3):221-30. PubMed ID: 10090668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias.
    Mott RT; Dickson DW; Trojanowski JQ; Zhukareva V; Lee VM; Forman M; Van Deerlin V; Ervin JF; Wang DS; Schmechel DE; Hulette CM
    J Neuropathol Exp Neurol; 2005 May; 64(5):420-8. PubMed ID: 15892300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration.
    Delacourte A
    Biomed Pharmacother; 1994; 48(7):287-95. PubMed ID: 7858159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathological discrepancy between Japanese Pick's disease without Pick bodies and frontal lobe degeneration type of frontotemporal dementia proposed by Lund and Manchester Group.
    Ikeda K
    Neuropathology; 2000 Mar; 20(1):76-82. PubMed ID: 10935442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective expression of Ser 199/202 phosphorylated tau in a case of frontotemporal dementia.
    Takamatsu J; Kondo A; Ikegami K; Kimura T; Fujii H; Mitsuyama Y; Hashizume Y
    Dement Geriatr Cogn Disord; 1998; 9(2):82-9. PubMed ID: 9524799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Their relevance for understanding the neurogenerative process.
    Goedert M; Ghetti B; Spillantini MG
    Ann N Y Acad Sci; 2000; 920():74-83. PubMed ID: 11193179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia ("pallido-ponto-nigral degeneration").
    Reed LA; Schmidt ML; Wszolek ZK; Balin BJ; Soontornniyomkij V; Lee VM; Trojanowski JQ; Schelper RL
    J Neuropathol Exp Neurol; 1998 Jun; 57(6):588-601. PubMed ID: 9630238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Demonstration of a specific profile of pathological Tau proteins in frontotemporal dementia cases].
    Vermersch P; Bordet R; Ledoze F; Ruchoux MM; Chapon F; Thomas P; Destée A; Lechevallier B; Delacourte A
    C R Acad Sci III; 1995 Apr; 318(4):439-45. PubMed ID: 7648357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pick's disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment.
    Probst A; Tolnay M; Langui D; Goedert M; Spillantini MG
    Acta Neuropathol; 1996 Dec; 92(6):588-96. PubMed ID: 8960316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau, ubiquitin, and alpha B-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia.
    Cooper PN; Jackson M; Lennox G; Lowe J; Mann DM
    Arch Neurol; 1995 Oct; 52(10):1011-5. PubMed ID: 7575218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L).
    Bird TD; Nochlin D; Poorkaj P; Cherrier M; Kaye J; Payami H; Peskind E; Lampe TH; Nemens E; Boyer PJ; Schellenberg GD
    Brain; 1999 Apr; 122 ( Pt 4)():741-56. PubMed ID: 10219785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau protein expression in frontotemporal dementias.
    Adamec E; Chang HT; Stopa EG; Hedreen JC; Vonsattel JP
    Neurosci Lett; 2001 Nov; 315(1-2):21-4. PubMed ID: 11711205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins.
    Buée-Scherrer V; Buée L; Hof PR; Leveugle B; Gilles C; Loerzel AJ; Perl DP; Delacourte A
    Am J Pathol; 1995 Apr; 146(4):924-32. PubMed ID: 7717459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.